Acute intrathecal baclofen withdrawal: a brief review of treatment options
- PMID: 20717751
- DOI: 10.1007/s12028-010-9422-6
Acute intrathecal baclofen withdrawal: a brief review of treatment options
Abstract
Background: Acute baclofen toxicity and withdrawal can present with a constellation of symptoms making differentiation between these two entities and other potential diagnoses challenging. Baclofen withdrawal is associated with numerous complications which may require neurocritical care expertise such as respiratory failure, refractory seizures, delirium, and blood pressure lability.
Methods: Case report and literature review.
Results: This case report discusses a case of intrathecal baclofen (ITB) withdrawal, focusing on the differential diagnosis for acute baclofen withdrawal and reviews the various options that exist to treat the symptoms of acute baclofen withdrawal such as benzodiazepines, propofol, skeletal muscle relaxants, and tizanidine.
Conclusions: Critical care practitioners should be prepared to treat this potentially devastating and often refractory complication of ITB therapy.
Similar articles
-
Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement.J Toxicol Clin Toxicol. 2003;41(1):83-5. doi: 10.1081/clt-120018277. J Toxicol Clin Toxicol. 2003. PMID: 12645974
-
Infusion of intrathecal baclofen for acute withdrawal. Technical note.J Neurosurg. 2007 Oct;107(4):878-80. doi: 10.3171/JNS-07/10/0878. J Neurosurg. 2007. PMID: 17937239
-
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.Pain Physician. 2015 Jul-Aug;18(4):E633-41. Pain Physician. 2015. PMID: 26218954
-
Intrathecal baclofen withdrawal: a case report and review of the literature.Childs Nerv Syst. 2002 Oct;18(9-10):522-5. doi: 10.1007/s00381-002-0634-8. Epub 2002 Jul 23. Childs Nerv Syst. 2002. PMID: 12382179 Review.
-
Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management.J Neurosurg. 2005 Jun;102(6):1133-6. doi: 10.3171/jns.2005.102.6.1133. J Neurosurg. 2005. PMID: 16028775 Review.
Cited by
-
Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithm.Neurol Clin Pract. 2014 Apr;4(2):123-130. doi: 10.1212/cpj.0000000000000000. Neurol Clin Pract. 2014. PMID: 29443199 Free PMC article.
-
A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.Crit Rev Phys Rehabil Med. 2013;25(1-2):11-22. doi: 10.1615/CritRevPhysRehabilMed.2013007945. Crit Rev Phys Rehabil Med. 2013. PMID: 25750484 Free PMC article.
-
Neurological adverse events associated with baclofen: A disproportionality analysis based on FDA Adverse Event Reporting System.SAGE Open Med. 2025 Apr 28;13:20503121251331812. doi: 10.1177/20503121251331812. eCollection 2025. SAGE Open Med. 2025. PMID: 40303631 Free PMC article.
-
Paradoxical and bidirectional drug effects.Drug Saf. 2012 Mar 1;35(3):173-89. doi: 10.2165/11597710-000000000-00000. Drug Saf. 2012. PMID: 22272687 Review.
-
Streptococcus dysgalactiae-related intrathecal baclofen therapy infection: how to avoid withdrawal?New Microbes New Infect. 2021 Mar 24;41:100875. doi: 10.1016/j.nmni.2021.100875. eCollection 2021 May. New Microbes New Infect. 2021. PMID: 33898045 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources